Past Conference Report - Cancer Research

With great support from our Collaborators and Organizing Committee, PULSUS Conferences successfully completed the “Cancer 2018” which was held at Edinburgh, Scotland on March 26-27, 2018.

We would like to thank our Keynote Speakers for the conference - Hiroshi Kobayashi, Chiba University, Japan, William T. Beck, University of Illinois, USA, Shalini Gupta, King George Medical College, India, Antonio Gomez-Munoz, University Of The Basque Country, Spain, Barbara DeVivo, Westmont University, USA. for their support in making this event a great success.

We would like to extend our thanks to our collaborators “Sudanese Medical Research Association”, “Uganda Cancer Society” and “Pharmaceutical Society of Uganda” for their constant support. It wouldn’t have been possible without the support of our Media Partners who helped us in promoting this event. We thank our Media partners for their support in helping us reach a greater audience.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events.

With a great response and feedback which we received at this event, Pulsus Conferences is proud to announce our upcoming conferences in the Series of Oncology Conferences-

“25th Global Meet on Cancer Research & Oncology”- Rome, Italy on May 20-21, 2019.

Past conference photos:

Comments

Poster Presentation - Influence of NECC (Nutrition and Exercise Center for Cancer Patients) on survival and body composition in Gastrointestinal Cancer Patients

Abstract BACKGROUND : Gastrointestinal cancer patients are particularly predisposed to develop cancer cachexia. Cachectic patients are characterized by loss of adipose tissue as well as skeletal muscle wasting which has a tremendous impact on quality of life and survival (1, 4). In terms of improvement for this multifactorial syndrome, Klinikum rechts der Isar (MRI) in Munich, Germany has founded NECC, a treatment concept including nutrition intervention and an individual training program. METHODS : In this study we focused on patients with pancreatic (n =15) and upper gastrointestinal cancer (n = 21). Body composition using CT images was analyzed initially, 4 weeks, 3 months and 6 months after initial visit of NECC (Image 1). To underline the outcome, NECC patients were matched to adequate partners who correspond in age, gender, diagnosis with TNM classification and type of surgery. The control group does not receive any further support concerning nutrition and physical exercise

Conference Venue

holiday Inn Rome - Aurelia,Via Aurelia Km, 8400 00165, Rome, Italy About City Rome is the capital city of Italy and Lazio region with 2,872,800 residents in 1,285 km2. It is the fourth most populous city in the European Union by population within city limits. Rome is located in central western Italian peninsulas. Rome has acquired the status of a global city. In 2016, Rome has been ranked as the 14th most visited cities in the world and 3rd most visited cities in Europe. It is a city that is proud of its ancient glorious heritage, a city that once expanded its empire throughout Europe, Africa and Asia. The city of Rome includes tourist places such as Colosseum, Pantheon, Spanish Steps, the Forum, Trevi Fountain, and the catacombs any of the buildings have arches, domes and vaults. Colosseum is one of the famous architecture symbols in Rome which is capable of housing 60,000 spectators and it is the largest amphitheater ever built in the Roman empire and it was used for gladia

Poster Presentation - The Notch ligand DLL1 exerts pro-carcinogenic effects in human breast cancer luminal A MCF-7 cells

Abstract Background: Breast cancer (BC) is the most common cancer in women and has a high rate of relapse and death. The Notch signaling pathway plays an important role in normal breast development and homeostasis. Dysregulation of Notch receptors and its ligands Jagged1, Jagged2, and DLL4 has been detected in BC and implicated in tumor development, progression, drug resistance, and recurrence. The Notch ligand DLL1 has emerged as a player in BC as its expression is undetectable in normal breast tissues, but moderate to high in BC. In this study, we examined the role of DLL1 in BC luminal A MCF-7 cells. Methodology: DLL1 siRNA and recombinant DLL1 protein were used to evaluate the effects of DLL1 in MCF-7 cells. Gene expression was analyzed by qRT-PCR and immunoblotting. Cell growth and proliferation were assessed by trypan blue exclusion and MTT methods. Microscopy and scratch wound-healing assays were used to evaluate colony formation and cell migration. Findings: In M

25th Global Meet on Cancer Research & Oncology

Search This Blog